Medtronic launches heart implant for atrial fibrillation, following Boston Scientifc, Abbott


The new product is aimed at closing the heart's left atrial appendage, which can help treat patients with atrial fibrillation. Rivals like Boston Scientific and Abbott already make devices for the fast-growing market.

Previous Crescent Communities acquires more land at The River District
Next Ransomware attack impacts Ardent Health Systems, Vanderbilt University Medical Center